SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients

…, MA Alfaleh, S Hala, TS Abujamel, SS Alamri… - Scientific reports, 2020 - nature.com
As the Coronavirus Disease 2019 (COVID-19), which is caused by the novel SARS-CoV-2,
continues to spread rapidly around the world, there is a need for well validated serological …

Early humoral response correlates with disease severity and outcomes in COVID-19 patients

…, SA Almahboub, MA Alfaleh, TS Abujamel, SS Alamri… - Viruses, 2020 - mdpi.com
… robust immune response is the viral spike (S) protein. S protein is comprised of S1 and S2
… As such, quantitative determination of antibodies against the S protein is widely used to …

The importance of combining serological testing with RT-PCR assays for efficient detection of COVID-19 and higher diagnostic accuracy

SS Alamri, A Alsaieedi, Y Khouqeer, M Afeef, S Alharbi… - PeerJ, 2023 - peerj.com
Misdiagnosing suspected COVID-19 individuals could largely contribute to the viruses
transmission, therefore, making an accurate diagnosis of infected subjects vital in minimizing and …

Immunogenicity of candidate MERS-CoV DNA vaccines based on the spike protein

SS Al-Amri, AT Abbas, LA Siddiq, A Alghamdi… - Scientific reports, 2017 - nature.com
… (S) protein-based vaccines. Here, we investigated the immunogenicity of naked DNA vaccines
expressing different fragments of MERS-CoV S … the MERS-CoV S protein could represent …

Synthetic SARS-CoV-2 spike-based DNA vaccine elicits robust and long-lasting th1 humoral and cellular immunity in mice

SS Alamri, KA Alluhaybi, RY Alhabbab… - Frontiers in …, 2021 - frontiersin.org
The ongoing global pandemic of coronavirus disease 2019 (COVID-19) calls for an urgent
development of effective and safe prophylactic and therapeutic measures. The spike (S) …

A highly immunogenic, protective, and safe adenovirus-based vaccine expressing Middle East respiratory syndrome coronavirus S1-CD40L fusion protein in a …

…, A Algaissi, AS Agrawal, SS Al-Amri… - The Journal of …, 2019 - academic.oup.com
Sawsan S Al-amri , Sawsan S Al-amri … Vero E6 and Huh7.5 cells were cultured and maintained
in complete Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% heat-…

Seroprevalence of SARS-CoV-2 binding and neutralizing antibodies in healthcare workers during the epidemic peak in referral hospitals and quarantine sites: Saudi …

…, OI Shabouni, R Alhabbab, AA Alfaraj, SS Alamri… - Viruses, 2021 - mdpi.com
Healthcare workers (HCWs) are at high risk for SARS-CoV-2 infection compared to the general
population. Here, we aimed to evaluate and characterize the SARS-CoV-2 seropositivity …

Low clinical utility of testing for anti‐platelet factor 4 in asymptomatic individuals after ChAdOx1 nCoV‐19 vaccine

AS Barefah, OO Radhwi, SS Alamri… - … journal of laboratory …, 2022 - Wiley Online Library
Introduction The development of anti‐platelet factor 4 (PF4) antibodies is linked to a rare
thrombotic complication described now as vaccine‐induced immune thrombotic …

Amplifying lateral flow assay signals for rapid detection of COVID‐19 specific antibodies

…, MA Alfaleh, RM Alsulaiman, SS Alamri… - Global …, 2022 - Wiley Online Library
… (S) proteins while most available vaccines for emergency use generate antibodies specific …
S protein. Therefore, available SARS-CoV-2 LFIA devises that are specific for SARS-CoV-2 S

Development and validation of different indirect ELISAs for MERS-CoV serological testing

AM Hashem, SS Al-Amri, TL Al-Subhi, LA Siddiq… - Journal of …, 2019 - Elsevier
… as S protein microarray, IFA staining based on cells expressing recombinant full length S
protein… N, S1 and S proteins using a large number of well characterized human serum samples. …